Testing Antigens, Antibodies, and Immune Cells in COVID-19 as a Public Health Topic—Experience and Outlines
Open Access
- 14 December 2021
- journal article
- research article
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 18 (24) , 13173
Abstract
The current COVID-19 pandemic has triggered an accelerated pace in all research domains, including reliable diagnostics methodology. Molecular diagnostics of the virus and its presence in biological samples relies on the RT-PCR method, the most used and validated worldwide. Nonconventional tests with improved parameters that are in the development stages will be presented, such as droplet digital PCR or CRISPR-based assays. These molecular tests were followed by rapid antigen testing along with the development of antibody tests, whether based on ELISA platform or on a chemiluminescent microparticle immunoassay. Less-conventional methods of testing antibodies (e.g., lateral flow immunoassay) are presented as well. Left somewhere in the backstage of COVID-19 research, immune cells and, furthermore, immune memory cells, are gaining the spotlight, more so in the vaccination context. Recently, methodologies using flow-cytometry evaluate circulating immune cells in infected/recovered patients. The appearance of new virus variants has triggered a surge for tests improvement. As the pandemic has entered an ongoing or postvaccination era, all methodologies that are used to monitor public health focus on diagnostic strategies and this review points out where gaps should be filled in both clinical and research settings.Keywords
Funding Information
- NASR (PN 19.29.01.01)
This publication has 120 references indexed in Scilit:
- Antibody-profiling technologies for studying humoral responses to infectious agentsExpert Review of Vaccines, 2010
- New Algorithms and Methods to Estimate Maximum-Likelihood Phylogenies: Assessing the Performance of PhyML 3.0Systematic Biology, 2010
- Temporal changes in dendritic cell subsets, cross-priming and costimulation via CD70 control CD8+ T cell responses to influenzaNature Immunology, 2010
- The challenges of eliciting neutralizing antibodies to HIV-1 and to influenza virusNature Reviews Microbiology, 2008
- Coronavirus HKU1 and Other Coronavirus Infections in Hong KongJournal of Clinical Microbiology, 2006
- SARS–associated Coronavirus Replication in Cell LinesEmerging Infectious Diseases, 2006
- Cytokine Responses in Severe Acute Respiratory Syndrome Coronavirus-Infected Macrophages In Vitro: Possible Relevance to PathogenesisJournal of Virology, 2005
- Severe Acute Respiratory Syndrome (SARS)Journal of Clinical Virology, 2003
- Severe Acute Respiratory Syndrome (SARS) in Singapore: Clinical Features of Index Patient and Initial ContactsEmerging Infectious Diseases, 2003
- The hemagglutinin/esterase gene of human coronavirus strain OC43: Phylogenetic relationships to bovine and murine coronaviruses and influenza C virusVirology, 1992